A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability. PHASE1 "This study is a single-center, randomized, double-blinded and placebo-cont...
Show More Location
Huashan Hospital, Fudan University
Learn More & Join Trial
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis PHASE3 This is a multi-center, randomized, double-blind, parallel-group, active co...
Show More Location
Shanghai First People's Hospital
Learn More & Join Trial
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer PHASE3 This is a multi-center, randomized, double-blind, double-dummy, parallel-gr...
Show More Location
Beijing Friendship Hospital, Capital Medical University
Learn More & Join Trial
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks PHASE3 This is one multi-center, randomized, double-blind, parallel-group, placebo...
Show More Location
Shanghai East Hospital
Learn More & Join Trial